Literature DB >> 21732944

Neuroimaging in epilepsy: the state of the art.

Matthias H Schmidt1, Bernd Pohlmann-Eden.   

Abstract

Our understanding of epileptogenesis is still limited. Knowledge is increasing with regard to structural and functional changes in chronic stages of epilepsy. At the same time, we have to appreciate that there is a significant lack of such information in new-onset epilepsy. The First Halifax International Epilepsy Conference tried to fill this gap, focusing on the contribution of advanced neuroimaging in early stages of epilepsy. The following article aims to synthesize the themes that emerged from this meeting. Participants agreed that (1) there is a need for a unified theory of epileptogenesis, addressing the interplay of functional and structural brain changes; (2) neuroimaging reveals widespread brain alterations in epilepsy; (3) advances in neuroimaging challenge the concept of "MRI-negative" (magnetic resonance imaging negative) focal epilepsy; (4) methodologic limitations and potential confounders must be considered in the translation of innovative imaging approaches to clinical practice; and (5) there is an urgent need for longitudinal studies that begin early in the disease process. Wiley Periodicals, Inc.
© 2011 International League Against Epilepsy.

Entities:  

Mesh:

Year:  2011        PMID: 21732944     DOI: 10.1111/j.1528-1167.2011.03154.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  8 in total

1.  High-frequency oscillations, extent of surgical resection, and surgical outcome in drug-resistant focal epilepsy.

Authors:  Claire Haegelen; Piero Perucca; Claude-Edouard Châtillon; Luciana Andrade-Valença; Rina Zelmann; Julia Jacobs; D Louis Collins; François Dubeau; André Olivier; Jean Gotman
Journal:  Epilepsia       Date:  2013-01-07       Impact factor: 5.864

Review 2.  Neuroimaging the epileptogenic process.

Authors:  Sandy R Shultz; Terence J O'Brien; Maria Stefanidou; Ruben I Kuzniecky
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

3.  Computer-Aided Diagnosis and Localization of Lateralized Temporal Lobe Epilepsy Using Interictal FDG-PET.

Authors:  Wesley T Kerr; Stefan T Nguyen; Andrew Y Cho; Edward P Lau; Daniel H Silverman; Pamela K Douglas; Navya M Reddy; Ariana Anderson; Jennifer Bramen; Noriko Salamon; John M Stern; Mark S Cohen
Journal:  Front Neurol       Date:  2013-04-03       Impact factor: 4.003

4.  Progression of microstructural putamen alterations in a case of symptomatic recurrent seizures using diffusion tensor imaging.

Authors:  Jan S Gerdes; Simon S Keller; Wolfram Schwindt; Stefan Evers; Siawoosh Mohammadi; Michael Deppe
Journal:  Seizure       Date:  2012-04-28       Impact factor: 3.184

5.  Hemispheric Regional Based Analysis of Diffusion Tensor Imaging and Diffusion Tensor Tractography in Patients with Temporal Lobe Epilepsy and Correlation with Patient outcomes.

Authors:  Mahdi Alizadeh; Lauren Kozlowski; Jennifer Muller; Neha Ashraf; Shiva Shahrampour; Feroze B Mohamed; Chengyuan Wu; Ashwini Sharan
Journal:  Sci Rep       Date:  2019-01-18       Impact factor: 4.379

6.  Distinctive Patterns of Seizure-Related White Matter Alterations in Right and Left Temporal Lobe Epilepsy.

Authors:  Irena Buksakowska; Nikoletta Szabó; Lukáš Martinkovič; Péter Faragó; András Király; Jiří Vrána; Zsigmond Tamás Kincses; Jan Meluzín; Vlastimil Šulc; Martin Kynčl; Miloslav Roček; Michal Tichý; František Charvát; Daniel Hořínek; Petr Marusič
Journal:  Front Neurol       Date:  2019-10-01       Impact factor: 4.003

7.  The "natural" history of medically treated temporal lobe epilepsy: what can an evidence-based approach tell us?

Authors:  Colin Bruce Josephson; Bernhard Pohlmann-Eden
Journal:  Epilepsy Res Treat       Date:  2012-02-16

8.  Concomitant fractional anisotropy and volumetric abnormalities in temporal lobe epilepsy: cross-sectional evidence for progressive neurologic injury.

Authors:  Simon S Keller; Jan-Christoph Schoene-Bake; Jan S Gerdes; Bernd Weber; Michael Deppe
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.